Skip to main content
Effie Petersdorf, MD, Hematology, Seattle, WA, UW Medicine/University of Washington Medical Center

EffieWPetersdorfMD

Hematology Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Are you Dr. Petersdorf?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 90 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Effie Petersdorf, MD is a hematologist in Seattle, Washington. She is currently licensed to practice medicine in Washington. She is affiliated with Fred Hutchinson Cancer Center and UW Medicine/University of Washington Medical Center.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1988
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1982 - 1985
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1982

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1983 - 2026

Publications & Presentations

PubMed

Press Mentions

  • Dr. Fred Appelbaum Receives Lifetime Achievement Award
    Dr. Fred Appelbaum Receives Lifetime Achievement AwardFebruary 20th, 2023
  • New Genetic Clues to Why Most Bone Marrow Transplant Patients Develop Graft-Versus-Host Disease
    New Genetic Clues to Why Most Bone Marrow Transplant Patients Develop Graft-Versus-Host DiseaseSeptember 4th, 2012

Grant Support

  • Clinical Significance Of MHC Haplotypes In HCTNational Cancer Institute2003–2012
  • Genetic Mechanisms Of Survivorship Disparities After Unrelated HCTNational Cancer Institute2011
  • Hematopoietic Stem Cell And Cord Blood TransplantationNational Institute Of Allergy And Infectious Diseases2010–2011
  • Immunogenetics Of Graft-Versus-Host DiseaseNational Cancer Institute2007–2011
  • Hematopopietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2006–2009
  • Clinical Significance Of MHC Haplotypes In Hematopoietic Cell TransplantationNational Cancer Institute2007
  • Hematopoietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005
  • SNPS In Lung Cancer Risk And Therapeutic ResponseNational Cancer Institute2003–2004
  • Optimizing BMT For Cancer By Genetic Matching Of DonorsNational Cancer Institute1997–2003
  • Immune Deviation Or Tolerance Induced By Human Lymphoid DendriticNational Institute Of Allergy And Infectious Diseases2002
  • Functional Genomic Markers In Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2002
  • Identification Of Peptide Ligands Responsible For GVHDNational Institute Of Allergy And Infectious Diseases1996–1999

Hospital Affiliations